Ledger.Open graph →
SEC Form D · Amendment · filed August 4, 2023

MediSix Therapeutics, Inc

Offering
$22.5M
Sold
$22.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Michael D. Carusi · BOSTON, MADirectorWilliam A. Harrington · BOSTON, MADirectorAndrew R. Bruce · BOSTON, MAExec · DirectorGeorge A. Poste · BOSTON, MADirectorBrian E. Handly · Raleigh, NCDirectorNadir Noorani · Matthews, NCDirectorBinayak R. Mishra · New York, NYExec · DirectorAnup Desai · Matthews, NCDirectorDouglas R. Jamieson · Rye, NYDirectorWan Li Zhu · Roxbury, MADirectorJit Kee Chin · Roxbury, MADirectorPuneet Mahajan · Roxbury, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗